BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 27476048)

  • 21. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position.
    Iyer HS; Gomez SL; Chen JT; Trinh QD; Rebbeck TR
    Cancer; 2021 Jul; 127(14):2525-2534. PubMed ID: 33798264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
    J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
    Goovaerts P; Xiao H
    Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary risk profile of prostate cancer in the United States.
    Shao YH; Demissie K; Shih W; Mehta AR; Stein MN; Roberts CB; Dipaola RS; Lu-Yao GL
    J Natl Cancer Inst; 2009 Sep; 101(18):1280-3. PubMed ID: 19713548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
    Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Steele CB; Li J; Huang B; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
    Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
    Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
    Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
    Defever K; Platz EA; Lopez DS; Mondul AM
    Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.
    Gadgeel SM; Severson RK; Kau Y; Graff J; Weiss LK; Kalemkerian GP
    Chest; 2001 Jul; 120(1):55-63. PubMed ID: 11451816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
    Menashe I; Anderson WF; Jatoi I; Rosenberg PS
    J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.